When was Asimov founded?

Asimov was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is Asimov located?

Asimov is headquartered in Boston, United States. It is registered at Boston, Massachusetts.

Who is the current CEO of Asimov?

Alec Nielsen and Alec Nielsen s of Asimov. Alec Nielsen has also founded 1 company and is angel investors in 7 startups, including Petri.

How many employees does Asimov have?

As of Aug 31, 2026, the latest employee count at Asimov is 120.

Is Asimov a funded company?

Asimov is a funded company, having raised a total of $234M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 04, 2017.

When was the latest funding round of Asimov?

Asimov's latest funding was a $***** Series B round on Jan 05, 2023, with participation from 7 investors.

Where does Asimov rank among its competitors?

Asimov ranks 18th amongst 478 active competitors, of which 193 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Ginkgo Bioworks, which secured an undisclosed amount in Dec, 2023.

Who are the top competitors of Asimov?

Asimov's top competitors include Ginkgo Bioworks, Syngenta and Spark Therapeutics. Among them, Ginkgo Bioworks secured the most recent funding round in December, 2023.

Asimov - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of integrated suite for advanced genetic design and manufacturing. The platform offers cloud-based software and advanced genetic design tools to optimize the development and manufacture of biologics, cell therapies, and gene therapies.

Website: www.asimov.com/
Social
Registered Address: Boston, Massachusetts

Key Metrics

Founded Year

2017

Location

Boston, United States

Stage

Series B

Total Funding

$234M in 8 rounds

Latest Funding Round

Series B, Jan 05, 2023, $*****

Investors

Andreessen Horowitz & 12 more

Ranked

18^th among 478 active competitors

Employee Count

120 as on Aug 31, 2026

Similar Companies

Ginkgo Bioworks & 2693 more

View Asimov's full profile

Asimov is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ASIMOV INC CIN: 815026684 , United States, Active	Dec 31, 1999	-	70 (As on Dec 31, 2024)	-

Asimov has raised a total funding of $234M over 8 rounds. Its first funding round was on Apr 04, 2017. Its latest funding round was a Series B round on Jan 05, 2023 for $*****. 7 investors participated in its latest round. Asimov has 13 institutional investors.

Here is the list of recent funding rounds of Asimov:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 05, 2023	4158420	Series B	8626637	8724534	9683914	5256566
2020	9275	Series A	1864	3241	9503	7920
May 22, 2019	4291409	Series A	6591844	7709037	9169818	6222235

Access funding benchmarks and valuations. Sign up today!

View details of Asimov's funding rounds and investors

The founders of Asimov are Alec Nielsen, Alec Nielsen, Douglas Densmore and Raja Srinivas. Alec Nielsen is the CEO of Asimov.

Here are the details of Asimov's key team members:

Alec Nielsen: Co-Founder & CEO of Asimov and founder of 2 other companies, Petri and Asimov. They are also an angel investor in 7 startups.
Contact Info: 2 email addresses
Alec Nielsen: Co-Founder & CEO of Asimov.
Douglas Densmore: Co-Founder of Asimov and founder of 1 other company.
Contact Info: 2 email addresses
Raja Srinivas: Founder of Asimov and founder of 1 other company.
Contact Info: 2 email addresses

View details of Asimov's Founder profiles and Board Members

Asimov's employee count trend

Asimov has 120 employees as of Aug 26. Here is Asimov's employee count trend over the years:

Uncover Asimov's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Asimov include Ginkgo Bioworks, Syngenta and Spark Therapeutics. Here is the list of Top 10 competitors of Asimov, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
3rd	Spark Therapeutics 2013, Philadelphia (United States), Acquired	Developer of gene therapy for rare diseases	$82.8M	Sofinnova Investments, T. Rowe Price & 6 others	73/100
4th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Fidelity Investments & 39 others	72/100
5th	Beam Therapeutics 2017, Cambridge (United States), Public	Developer of gene therapy using CRISPR base editing to treat diseases	$222M	F-Prime Capital, Google Ventures & 16 others	71/100
6th	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	71/100
7th	Passage Bio 2017, Philadelphia (United States), Public	Developer of gene therapies for CNS rare diseases	$226M	Access Biotechnology, Orbimed & 10 others	69/100
8th	Generation Bio 2016, Cambridge (United States), Acquired	Developer of gene therapies for rare liver and eye diseases	$236M	T. Rowe Price, Fidelity Investments & 9 others	69/100
9th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	EDBI, Vivo Capital & 12 others	68/100
10th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
18th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$234M	Fidelity Investments, AME Cloud Ventures ... & 11 others	65/100